Journal profile · Dermatology
Experimental Dermatology
ISSN 0906-6705 · eISSN 1600-0625 · Wiley-Blackwell Publishing Ltd · DENMARK · Bimonthly · Founded 1992
Experimental Dermatology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.4; hybrid open access; APC about USD 4,880; median 146 days to acceptance (99 articles, last 24 months); community-reported acceptance: about 25%; 181 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Experimental Dermatology is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dermatology and Skin Diseases, melanin and skin pigmentation and Skin Protection and Aging, together about 30.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Experimental Dermatology provides a vehicle for the rapid publication of innovative and definitive reports, letters to the editor and review articles covering all aspects of experimental dermatology. Preference is given to papers of immediate importance to other investigators, either by virtue of their new methodology, experimental data or new ideas. The essential criteria for publication are clarity, experimental soundness and novelty. Letters to the editor related to published reports may also be accepted, provided that they are short and scientifically relevant to the reports mentioned, in order to provide a continuing forum for discussion. Review articles represent a state-of-the-art overview and are invited by the editors.
From the journal's Aims & Scope
Research area (LetPub): Dermatology
Editor-in-chief Dong Hun LeePublisher website
Editorial board by country: 4 in mainland China (about 10%); most named Germany 8, Taiwan, China 7, South Korea 6, Japan 5, Mainland China 4 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dermatology and Skin DiseasesMedicine14.1%
- melanin and skin pigmentationBiochemistry, Genetics and Molecular Biology8.2%
- Skin Protection and AgingMedicine8%
- Skin and Cellular Biology ResearchBiochemistry, Genetics and Molecular Biology6.5%
- Hair Growth and DisordersMedicine5.8%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology4.8%
- Autoimmune Bullous Skin DiseasesMedicine4.7%
- Wound Healing and TreatmentsMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.4LetPub ·
- Impact factor (publisher)
- 3.4Publisher website ·
- Impact factor (publisher) 2025
- 3.4Publisher website ·
- CiteScore 2026-06
- 6.6LetPub ·
- CiteScore (publisher)
- 6.6Publisher website ·
- CiteScore (publisher) 2025
- 6.6Publisher website ·
- SJR 2026-06
- 1.07LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 85LetPub ·
- h-index
- 145OpenAlex ·
- i10-index
- 3,571OpenAlex ·
- 2-year mean citedness
- 3.45OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 37.97%LetPub ·
Volume
- Articles per year
- 135LetPub ·
- Articles per year (publisher) 2025
- 144Publisher website ·
- Downloads per year (publisher) 2025
- 1,156,279Publisher website ·
Articles by year OpenAlex count · 6,413 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 174 | 92 | 67 |
| 2025 | 181 | 115 | 427 |
| 2024 | 241 | 148 | 1,560 |
| 2023 | 287 | 193 | 2,229 |
| 2022 | 228 | 107 | 2,998 |
| 2021 | 252 | 113 | 4,327 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
146 daysMedian, submission to acceptance · P25–P75 90 days – 205 days
- Acceptance to online
- median 14 days (104 articles)
- Submission to online
- median 162 days
- Sample
- 99 articles with submission and acceptance dates (370 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Acceptance rate (publisher)
- 13%Publisher website ·
- Acceptance rate (publisher) 2025
- 13%Publisher website ·
- Submission to first decision
- 57 daysPublisher website ·
- Submission to first decision 2025
- 57 daysPublisher website ·
- Submission to acceptance 2025
- 179 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,880 / EUR 4,090 / GBP 3,230 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Keywords
- ≤ 5
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Required
- Cover letter
- Optional
Article types accepted3, with length limits
- original paperWhenever possible, authors are strongly encouraged to emphasize the clinical relevance of their work. In original papers, at least the final paragraph of the pa…Length not stated
- original researchCommunication Less comprehensive, short original research manuscripts including pilot studies Word limit: 2,000 words maximum. Abstract: 200 words maximum. Figu…main text ≤ 2,000 words
- research articlefindings, whenever this makes sense. i. Research Article Word limit: 5,000 words maximum, excluding abstract, tables, figures and referencesmain text ≤ 5,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Trial registration / reporting guidelines
- Authorship Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing eligibility.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors are required to submit a statement on conflicts of interests within their manuscript. If there are none, this should be stated. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statemen…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Please review Wiley’s policy here. This journal encourages and peer review data sharing.
Source ↗Publisher website ·- Publication ethics Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Open access Publishing Open Access? Your fees may be covered
Click on the Altmetric banner to view the latest trending articles from Experimental Dermatology
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editors determine that the paper meets the appropriate quality, publication priority and relevance requirements.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- DENMARK
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1992
- ISSN
- 0906-6705
- Electronic ISSN
- 1600-0625
- Latest issue on the website
- Volume 35, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Experimental Dermatology
What CAS zone is Experimental Dermatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Experimental Dermatology is in Zone 3 of Medicine, and in Zone 2 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Experimental Dermatology?
The latest impact factor listed by LetPub is 3.4; CiteScore 6.6, h-index 145.
How long does peer review take at Experimental Dermatology?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 146 days (interquartile range 90–205 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 25%”; the journal's website gives an acceptance rate of 13% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Experimental Dermatology?
According to the journal's author guidelines: Keywords: ≤ 5; Reference style: AMA; First submission: Free format: the journal's layout is not required; Graphical abstract: Required; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Experimental Dermatology based?
Of the 41 board members whose country the journal's board page names, 4 (about 10%) are in mainland China; the countries named most often are Germany (8), Taiwan, China (7) and South Korea (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Experimental Dermatology?
According to LetPub and DOAJ records, Experimental Dermatology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Experimental Dermatology open access, and what is the APC?
Experimental Dermatology is a hybrid journal. For open-access publication: APC about USD 4,880.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .